Delivery Order SPE2DB24D1007-SPE2DB24FCAEY
Award Date
8/22/24
Potential Completion Date
8/23/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to AmerisourceBergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The award has a ceiling value of $6,509.96 and an ultimate completion date of August 5, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen is a major supplier of pharmaceutical products and medical supplies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp Corporate Office Division, a major pharmaceutical distributor. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $24,219.51 and an ultimate completion date of August 2, 2024. The contract is a Firm Fixed Price type and has no set-aside designation. AmerisourceBergen has been awarded multiple Indefinite Delivery Contracts (IDCs) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product, under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025. The delivery order has a ceiling value of $23,398.17 and a firm fixed price pricing type. The contract does not have a set-aside designation and is...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $15,351.82 firm fixed-price contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a pharmaceutical product. The contract has a completion date of September 20, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by various defense and civilian agencies to...
This delivery order contract, valued at $8,569.49, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product. The contract has a completion date of September 23, 2024 and is structured as a firm fixed price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple federal contracts and Indefinite Delivery...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, with a ceiling value of $9,995.66. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company. The contract is for the supply of GARDASIL 9 SYRINGE 0.5ML, a vaccine product, at a ceiling value of $6,399.38. The contract has a firm fixed price pricing type and a final completion date of September 27, 2024. Amerisourcebergen has been awarded numerous federal contracts and Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $4,066.74, is for the supply of 4,566,035,600 units of the GARDASIL 9 vaccine syringe (0.5 mL) to support federal healthcare programs. The contract has an ultimate completion date of October 8, 2024, and is a firm-fixed-price, non-set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of GARDASIL 9 syringes. The contract has a ceiling value of $18,527.80 and an ultimate completion date of July 29, 2024. It is a firm-fixed-price contract and is not set aside for any special program. AmerisourceBergen Drug Corp, through its Corporate Office Division, is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of GARDASIL 9 SYRINGE 0.5ML. The contract has a firm fixed price, with a ceiling value of $13,152.10, and an ultimate completion date of May 30, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...